Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary
This study is designed to evaluate the value of tissue-of-origin (ORIGIN-PanCA○R) profiling in predicting primary site and directing therapy in patients with cancer of unknown primary.
Cancer of Unknown Primary Site
GENETIC: tissue-of-origin (ORIGIN-PanCA○R) profiling
progression free survival, 6 months
overall response rate, 2 months|overall survival, 12 months|Adverse Events, 2 months|biomarker analysis, 6 months
This study is designed to evaluate the value of tissue-of-origin (ORIGIN-PanCA○R) profiling in predicting primary site and directing therapy in patients with cancer of unknown primary.